The company will evaluate the Hepzato kit as a combination therapy with the standard of care in patients with liver-dominant ...

Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the U.S. Food and Drug Administration ...

His interview on the "A Cure In Sight" YouTube channel helped me understand the treatment landscape for metastatic Uveal Melanoma (mUM) patients with liver-dominant cancer. He said the first step ...

Uveal melanoma is the most common type of eye cancer in adults ... the cancer has grown into tissues around the eye or another part of the body, such as the liver. If your cancer has grown into the ...

Additionally, PDE2A expression was closely related to the prognosis of cancers such as stomach adenocarcinoma (STAD), ovarian serous cystadenocarcinoma (OV), and liver hepatocellular ... 0.011), STAD ...

1 Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, United Kingdom 2 Kellogg College, University of Oxford, Oxford, United Kingdom Melanoma of the uveal tract or ...

Dr. Skalet’s research focuses on uveal melanoma, focusing upon early detection and vision ... Dr. Rocha’s research focuses on treatment of liver, pancreas, and biliary tumors. Stephen Roberts, MD, ...

The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak ...